Potential central nervous system antitumor agents. Hydantoin derivatives

Area of Science:

• Medicinal Chemistry
• Oncology
• Pharmacology

Background:

• Nitrogen mustards are effective chemotherapeutic agents but face challenges in targeting specific tumors, particularly brain tumors.
• Developing drug delivery systems that enhance tumor penetration and efficacy is crucial for improving cancer treatment outcomes.

Purpose of the Study:

• To synthesize and evaluate novel hydantoin derivatives as carriers for nitrogen mustards.
• To assess the efficacy of these novel compounds against central nervous system (CNS) tumors and other cancer models.

Main Methods:

• Synthesis of hydantoin derivatives with varying lipophilic characteristics.
• Antitumor activity evaluation in a murine ependymoblastoma brain tumor model.
• Assessment of compound activity in other cancer models, including leukemia, melanoma, and lung carcinoma.

Main Results:

• Three out of four examined hydantoin analogs demonstrated significant antitumor activity.
• Multiple complete cures were observed in the murine ependymoblastoma brain tumor system.
• The compounds also exhibited activity against intraperitoneal leukemia (L1210 and P388), B16 melanoma, and Lewis lung carcinoma.

Conclusions:

• Hydantoin derivatives can serve as effective carriers for nitrogen mustards, enhancing their antitumor properties.
• These novel compounds show potential for treating CNS malignancies and other cancers.
• Further investigation into these hydantoin-based nitrogen mustards is warranted for clinical development.